Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems

Journal of Liposome Research

Volumn 22, Issue 3, 2012, Pages 193-204

  Gordon, Sarah ^a,c   Young, Katherine ^a   Wilson, Rachel ^a   Rizwan, Shakila ^b   Kemp, Roslyn ^b   Rades, Thomas ^a   Hook, Sarah ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Immune response; Particulate delivery systems; Sustained release delivery systems; Thermosensitive hydrogel

Indexed keywords

ANTIBODY; CHITOSAN; CUBOSOME; GAMMA INTERFERON; LIPOSOME; OVALBUMIN; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HYDROGEL; IMMUNOGENICITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; FLOW CYTOMETRY; HYDROGELS; IMMUNITY, HUMORAL; INTERFERON-GAMMA; LIPOSOMES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PARTICLE SIZE; SAPONINS; VACCINES;

EID: 84865225071     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2011.637502     Document Type: Article

References (60)

1. Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
2. Barnden, M. J., Allison, J., Heath, W. R., Carbone, F. R. (1998). Defective TCR expression in transgenic mice constructed using cDNA-based a- and b-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34-40. (Pubitemid 28194695)
3. Bramwell, V. W., Perrie, Y. (2005). Particulate delivery systems for vaccines. Crit Rev Ther Drug Carrier Syst 22:151-214. (Pubitemid 41557321)
4. Brgles, M., Jurašin, D., Sikiri?, M. D., Frkanec, R., Tomaši?, J. (2008). Entrapment of ovalbumin into liposomes-factors affecting entrapment efficiency, liposome size, and zeta potential. J Liposome Res 18:235-248.
5. Casals, E., Soler, M., Gallardo, M., Estelrich, J. (1998). Electrophoretic behavior of stearylamine-containing liposomes. Langmuir 14:7522-7526. (Pubitemid 128585055)
6. Chenite, A., Buschmann, M., Wang, D., Chaput, C., Kandani, N. (2001). Rheological characterisation of thermogelling chitosan/ glycerol-phosphate solutions. Carbohydr Polym 46:39-47. (Pubitemid 32487087)
7. Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. D., Hoemann, C. D., et al. (2000). Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21:2155-2161. (Pubitemid 30612386)
8. Chikh, G., Schutze-Redelmeir, M. -P. (2002). Liposomal delivery of CTL epitopes to dendritic cells. Biosci Rep 22:339-353. (Pubitemid 35222740)
9. Cho, J., Heuzey, M. -C., Begin, A., Carreau, P. J. (2005). Physical gelation of chitosan in the presence of β-glycerophosphate: the effect of temperature. Biomacromolecules 6:3267-3275. (Pubitemid 41764088)
10. Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., et al. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine 21:883-890. (Pubitemid 36126422)
11. Demana, P. H., Fehske, C., White, K., Rades, T., Hook, S. (2004). Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes. Immunol Cell Biol 82:547-554. (Pubitemid 39421065)
12. Dong, Y. -D., Larson, I., Hanley, T., Boyd, B. J. (2006). Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir 22:9512-9518. (Pubitemid 44826357)
13. Ellis, R. W. (2001). Technologies for the design, discovery, formulation, and administration of vaccines. Vaccine 19:2681-2687. (Pubitemid 32234289)
14. Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., Frokjaer, S. (2004). Interaction of dendritic cells with antigen-containingliposomes: effect of bilayer composition. Vaccine 22:1903-1913. (Pubitemid 38581059)
15. Foged, C., Brodin, B., Frokjaer, S., Sundblad, A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315-322. (Pubitemid 40910735)
16. Gamvrellis, A., Leong, D., Hanley, J. C., Xiang, S. D., Mottram, P., Plebanski, M. (2004). Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 82:506-516. (Pubitemid 39421060)
17. Gasparri, J., Speroni, L., Chiaramoni, N. S., Valle Alonso, S. D. (2011). Relationship between the adjuvant and cytotoxic effects of the positive charges and polymerization in liposomes. J Liposome Res 21:124-133.
18. Gordon, S., Saupe, A., McBurney, W., Rades, T., Hook, S. (2008). Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. J Pharm Pharmacol 60:1591-1600.
19. Gregoriadis, G. (1990). Immunological adjuvants: a role for liposomes. Immunol Today 11:89-97. (Pubitemid 20062716)
20. Gupta, R. K. (1998). Aluminum compounds as vaccine adjuvants. Adv Drug Delivery Rev 32:155-172. (Pubitemid 28267407)
21. Han, I. -K., Kim, Y. B., Kang, H. -S., Sul, D., Jung, W. -W., Cho, H. J., et al. (2006). Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods 38:106-111. (Pubitemid 43163470)
22. Hecht, T. T., Longo, D. L., Matis, L. A. (1983). The relationship between immune interferon production and proliferation in antigenspecific, MHC-restricted T cell lines and clones. J Immunol 131:1049-1055. (Pubitemid 13041899)
23. Heeg, K., Kuon, W., Wagner, H. (1991). Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHCrestricted antigen pathway and allow sensitization against the immunodominant peptide. Eur J Immunol 21:1523-1527.
24. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., Carbone, F. R. (1994). T cell receptor antagonist peptides induce positive selection. Cell 76:17-27. (Pubitemid 24035278)
25. Kamath, A. T., Pooley, J., O'Keeffe, M. A., Vremec, D., Zhan, Y., Lew, A. M., et al. (2000). The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 165:6762-6770. (Pubitemid 32001141)
26. Kenney, R. T., Edelman, R. (2003). Survey of human-use adjuvants. Expert Rev Vaccines 2:167-188. (Pubitemid 36559923)
27. Kensil, C. R. (1996). Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst 13:1-55. (Pubitemid 26300177)
28. Kersten, G. F. A., Crommelin, D. J. A. (2003). Liposomes and ISCOMs. Vaccine 21:915-920. (Pubitemid 36126426)
29. Könnings, S., Copland, M. J., Davies, N. M., Rades, T. (2002). A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method. Int J Pharm 241:385-389. (Pubitemid 34718040)
30. Li, H., Willingham, S. B., Ting, J. P. -Y., Re, F. (2008). Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 181:17-21.
31. Lipford, G. B., Wagner, H., Heeg, K. (1994). Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12:73-80.
32. Lofthouse, S. (2002). Immunological aspects of controlled antigen delivery. Adv Drug Deliv Rev 54:863-870. (Pubitemid 35284015)
33. Lonez, C., Vandenbranden, M., Ruysschaert, J. -M. (2008). Cationic liposomal lipids: from gene carriers to cell signaling. Prog Lipid Res 47:340-347.
34. Macatonia, S. E., Doherty, T. M., Knight, S. C., O'Garra, A. (1993). Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 150:3755-3765. (Pubitemid 23129757)
35. McBurney, W. T., Lendemans, D. G., Myschik, J., Hennessy, T., Rades, T., Hook, S. (2008). In vivo activity of cationic immune stimulating complexes (PLUSCOMs). Vaccine 26:4549-4556.
36. Myschik, J., McBurney, W. T., Hennessy, T., Phipps-Green, A., Rades, T., Hook, S. (2008). Immunostimulatory biodegradable implants containing the adjuvant Quil-A. Part II: in vivo evaluation. J Drug Target 16:224-232. (Pubitemid 351460651)
37. Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., et al. (1997). Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 240:793-797. (Pubitemid 28271799)
38. Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., et al. (1999). Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Control Release 61:233-240. (Pubitemid 29406095)
39. O'Hagan, D. T. (2001). Recent developments in vaccine delivery systems. Curr Drug Targets Infect Disord 1:273-286.
40. Peek, L. J., Middaugh, C. R., Berkland, C. (2008). Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915-928.
41. Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., Bramwell, V. W. (2008). Vaccine adjuvant systems: enhancing the efficacy of subunit protein antigens. Int J Pharm 364:272-280.
42. Rao, M., Alving, C. R. (2000). Delivery of lipids and liposomal proteins to the cytoplasm and golgi of antigen-presenting cells. Adv Drug Deliv Rev 41:171-188. (Pubitemid 30122957)
43. Rizwan, S. B., Assmus, D., Boehnke, A., Hanley, T., Boyd, B. J., Rades, T., et al. (2011). Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm 79:15-22.
44. Rizwan, S. B., Dong, Y. D., Boyd, B. J., Rades, T., Hook, S. (2007). Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 38:478-485. (Pubitemid 46413070)
45. Rizwan, S. B., Hanley, T., Boyd, B. J., Rades, T., Hook, S. (2009). Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling, and release kinetics. J Pharm Sci 98:4191-4204.
46. Ruel-Gariépy, E., Chenite, A., Chaput, C., Guirguis, S., Leroux, J. -C. (2000). Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 203:89-98. (Pubitemid 30627629)
47. Senior, J. H., Trimble, K. R., Maskiewicz, R. (1991). Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim Biophys Acta 1070:173-179.
48. Sjölander, A., van't Land, B., Bengtsson, K. L. (1997). ISCOMs containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses. Cell Immunol 177:69-76. (Pubitemid 27192324)
49. Soltysik, S., Wu, J. -Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., et al. (1995). Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13:1403-1410.
50. Spicer, P. T. (2005). Progress in liquid crystalline dispersions: cubosomes. Curr Opin Coll Interf Sci 10:274-279. (Pubitemid 41682495)
51. Storni, T., Kündig, T. M., Senti, G., Johansen, P. (2005). Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev 57:333-355. (Pubitemid 39555501)
52. Tao Liang, M., Davies, N. M., Blanchfield, J. T., Toth, I. (2006). Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Deliv 3:379-388. (Pubitemid 44534050)
53. Upham, J. W., Strickland, D. H., Robinson, B. W., Holt, P. G. (1997). Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages. Thorax 52:786-795. (Pubitemid 27412558)
54. Vangala, A., Bramwell, V. W., McNeil, S., Christensen, D., Agger, E. M., Perrie, Y. (2007). Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. J Control Release 119:102-110. (Pubitemid 46561543)
55. Vangasseri, D. P., Cui, Z., Chen, W., Hokey, D. A., Falo, L. D., Huang, L. (2006). Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 23:385-395. (Pubitemid 44630022)
56. White, K., Rades, T., Kearns, P., Toth, I., Hook, S. (2006). Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res 23:1473-1481. (Pubitemid 43993810)
57. Yaghmur, A., Glatter, O. (2009). Characterization and potential applications of nanostructured aqueous dispersions. Adv Coll Interf Sci 147-148:333-342.
58. Zaharoff, D. A., Rogers, C. J., Hance, K. W., Schlom, J., Greiner, J. W. (2007). Chitosan solution enhances both humoral and cellmediated immune responses to subcutaneous vaccination. Vaccine, 25:2085-2094. (Pubitemid 46227669)
59. Zhao, Z., Leong, K. W. (1996). Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci 85:1261-1270. (Pubitemid 27014177)
60. Zinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., Hengartner, H. (1997). Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 156:199-209. (Pubitemid 27197203)